14 March 2019

The finalists of the scientific pitch competition Radboud Talks have been determined! A jury consisting of high school students from the Canisius college in Nijmegen chose the contestants who presented their research in the most clear and charismatic way during the two preliminaries on 11 and 13 March. On Monday night 25 March, those eight scientists will compete in LUX for the prize of 1,000 euro.

The eight diverse scientists from the Radboud university and Radboud university medical center will present their research on 25 March in short, clear and attractive pitches. Graphs and boring lists are strictly prohibited at Radboud Talks, it’s all about inspiring stories! Of the eight finalists, five are affiliated with the Radboudumc:
  • Iris Brummelhuis, research physician 
  • Rob ter Horst, bioinformatician
  • Jeroen Slaats, molecular biologist
  • Joanna Szopinska-Tokov, microbiologist
  • Sarah Verhoeff, research physician
The other participants are: 
  • Lynn Eekhof, linguist (Faculty of Arts)
  • Simone Lederer, data scientist (Faculty of Science)
  • Suhas Vijayakumar, neuroscientist (Faculty of Social Sciences) 
The winner will be chosen by a jury of science communicators: science journalists Esther Thole and Jop de Vrieze, and programmer at Radboud Reflects Anouta de Groot. The audience can also vote for their favorite. Next to the science, there will be music by the Students Big Band Nijmegen and a literary summary by author Lisa Weeda from ‘De Nieuwe Oost’. Tickets are available from LUX Nijmegen.

Last year the final was sold out days in advance, so make sure to get your tickets in time!
 
Day: Monday 25 March
Time: 19.30 - 21.45
Location: LUX 7
Tickets: € 5.00, via LUX
 

Related news items


Jong KNCV organizes a Pitch competition for PhD candidates

13 August 2020

Are you a PhD candidate and would you like to win 500 euros with a pitch about your research? Young KNCV gives you that chance! During the KNCV Chemistry 2020 Evening on October 8th.

read more

Collective invasion induced by autocrine purinergic loop through connexin-43 hemichannels

13 August 2020

Peter Friedl and Paul Span show in Journal of Cell Biology that breastcancer cells release purines into the extracellular space via connexin-43 hemichannels to control collective invasion.

read more

TP53 allelic state is critical for diagnostic and prognostic precision in blood cancer

12 August 2020

An international study, in which Joop Jansen participated, shows that a double mutaton in TP53 gene deteriotes the prognosis of a rare form of blood cancer. If there is only one mutation or no mutation, then the prognosis is better.

read more

BCG vaccine is safe with no increased risk of COVID-19 symptoms says Mihai Netea

11 August 2020

The BCG vaccine has a general stimulatory effect on the immune system and is therefore effective against multiple infectious diseases - possibly also against COVID-19.

read more

650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more